Cytotoxic and antigen presenting functions of T helper-1-activated dendritic cells

OncoImmunology

Volumn 1, Issue 4, 2012, Pages 566-568

  Larmonier, Nicolas ^a   Bonnotte, Bernard ^b   Katsanis, Emmanuel ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b Institut Médical de Génétique et d Immunologie   (France)

Author keywords

Antigen presentation; Cytotoxic dendritic cells; iNOS; Th 1 lymphocytes; Tumor

Indexed keywords

DENDRITIC CELL VACCINE; FAS LIGAND; GAMMA INTERFERON; GLYCOPROTEIN P 15095; GRANZYME; INTERFERON ANTIBODY; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; N(G) METHYLARGININE; NITRIC OXIDE; PERFORIN; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR AGONIST; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; CONCENTRATION (PARAMETERS); CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INNATE IMMUNITY; LYMPHOCYTE MIGRATION; NONHUMAN; NOTE; PRIORITY JOURNAL; T HELPER 1 ACTIVATED DENDRITIC CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TUMOR CELL DESTRUCTION;

EID: 84875076511     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.19370     Document Type: Note

References (10)

1. Wesa AK, Storkus WJ. Killer dendritic cells: mechanisms of action and therapeutic implications for cancer. Cell Death Differ 2008, 15:51-7, http://dx.doi.org/10.1038/sj.cdd.4402243
2. Bonmort M, Dalod M, Mignot G, Ullrich E, Chaput N, Zitvogel L. Killer dendritic cells: IKDC and the others. Curr Opin Immunol 2008, 20:558-65, http://dx.doi.org/10.1016/j.coi.2008.04.006
3. Larmonier N, Fraszczak J, Lakomy D, Bonnotte B, Katsanis E. Killer dendritic cells and their potential for cancer immunotherapy. Cancer Immunol Immunother 2010, 59:1-11, http://dx.doi.org/10.1007/s00262-009-0736-1
4. Chauvin C, Josien R. Dendritic cells as killers: mechanistic aspects and potential roles. J Immunol 2008, 181:11-6
5. Chan CW, Housseau F. The 'kiss of death' by dendritic cells to cancer cells. Cell Death Differ 2008, 15:58-69, http://dx.doi.org/10.1038/sj.cdd. 4402235
6. Chan CW, Crafton E, Fan HN, Flook J, Yoshimura K, Skarica M, et al. Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity. Nat Med 2006, 12:207-13, http://dx.doi.org/10.1038/nm1352
7. Blasius AL, Barchet W, Cella M, Colonna M. Development and function of murine B220+CD11c+NK1.1+ cells identify them as a subset of NK cells. J Exp Med 2007, 204:2561-8, http://dx.doi.org/10.1084/jem.20070991
8. Fraszczak J, Trad M, Janikashvili N, Cathelin D, Lakomy D, Granci V, et al. Peroxynitrite-dependent killing of cancer cells and presentation of released tumor antigens by activated dendritic cells. J Immunol 2010, 184:1876-84, http://dx.doi.org/10.4049/jimmunol.0900831
9. Chauvin C, Philippeau JM, Hémont C, Hubert FX, Wittrant Y, Lamoureux F, et al. Killer dendritic cells link innate and adaptive immunity against established osteosarcoma in rats. Cancer Res 2008, 68:9433-40, http://dx.doi.org/10.1158/0008-5472.CAN-08-0104
10. Lacasse CJ, Janikashvili N, Larmonier CB, Alizadeh D, Hanke N, Kartchner J, et al. Th-1 lymphocytes induce dendritic cell tumor killing activity by an IFN-cdependent mechanism. J Immunol 2011, 187:6310-7, http://dx.doi.org/10.4049/jimmunol. 1101812